Ashu Tandon, Chief Commercial Officer at Aragen, shares his perspective on the India contract manufacturing market, and the opportunities it presents for forward-thinking CDMOs and…
News Category: Media
India seeks a seat at the drug services table
For over a decade, China has been the preferred destination for US pharmaceutical companies looking to outsource drug development chemistry. Low labor costs, advanced infrastructure,…
Enhancing Supply Chain Flexibility and Resilience
The pandemic reshaped the CDMO market, making diversity of supplier base a necessity and an important variable in the supplier selection process. In light of…
DevsHealth announces strategic partnership with Aragen for the chemical synthesis of its projects
It is a key milestone to propel pipeline development and enhances DevsHealth relationship with India, a fast growing country on pharmaceutical industry DevsHealth is thrilled…
CDMO strategies for disrupting the biomanufacturing scale-up paradigm
According to data from S&P Global, the global biopharma market was estimated at $1.4 trillion in revenue in 2023. Of this total, markets outside the…
Developing capabilities to profile the next gen compounds in new modalities is expected to drive preclinical CRO growth
The preclinical Contract Research Organisation (CRO) sector in India is witnessing massive transformation with huge investments being made in this sector by domestic and multinational…
Clients add pressure to CDMOs to source raw materials outside of China, execs say
MILAN — CDMOs are increasingly fielding inquiries from biopharma clients on how reliant they are on China for their raw materials, off the back of…
Indian drug services companies unite
Eight Indian contract development and manufacturing organizations (CDMOs) have formed a trade group to boost the nation’s drug services industry. Manni Kantipudi, CEO of Aragen,…
Biologics Roundtable: The Current Landscape and Future Developments
In this joint discussion, we hear from Alex Del Piore at Syngene and Subodh Deshmukh at Aragen on why the biologics landscape has developed how…
Algorithms to Treatments: AI’s Impact on Modern Drug Discovery
Artificial Intelligence (AI) is revolutionizing drug discovery, shifting it from a lengthy and uncertain process to one marked by rapid precision and innovation in healthcare….
